OXBOF (Oxford BioDynamics) 6-Month Share Buyback Ratio: -119.19% (As of Mar. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Oxford BioDynamics 6-Month Share Buyback Ratio?

Oxford BioDynamics OXBOF 6-Month Share Buyback Ratio is -119.19 as of Mar. 2026. The stock has 4 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

6-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past six months, calculated as the percentage change in shares outstanding from two quarters ago to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Oxford BioDynamics's current 6-Month Share Buyback Ratio was -119.19%.

Oxford BioDynamics  (OTCPK:OXBOF) 6-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Oxford BioDynamics 6-Month Share Buyback Ratio Related Terms

OXBOF vs TMO, DHR, IDXX: 6-Month Share Buyback Ratio Comparison

For the Diagnostics & Research subindustry, Oxford BioDynamics's 6-Month Share Buyback Ratio, along with its competitors' market caps and 6-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford BioDynamics 6-Month Share Buyback Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Oxford BioDynamics's 6-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's 6-Month Share Buyback Ratio falls into.


Oxford BioDynamics 6-Month Share Buyback Ratio Calculation

Oxford BioDynamics's 6-Month Share Buyback Ratio for the quarter that ended in Mar. 2026 is calculated as

6-Month Share Buyback Ratio=(Shares Outstanding (EOP) (Sep. 2025 ) - Shares Outstanding (EOP) (Mar. 2026 )) / Shares Outstanding (EOP) (Sep. 2025 )
=(1957.578 - 4290.911) / 1957.578
=-119.19%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 6-Month Share Buyback Ratio of -119.19 mean?
Oxford BioDynamics (OXBOF) has a 6-Month Share Buyback Ratio of -119.19 as of Mar. 2026. The 6-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past six months, calculated as the percentage change in shares outstanding from two quarters ago to the current quarter. View historical data for Oxford BioDynamics and its competitors.
Is Oxford BioDynamics' 6-Month Share Buyback Ratio too high?
Oxford BioDynamics' current 6-Month Share Buyback Ratio is -119.19.
How does Oxford BioDynamics' 6-Month Share Buyback Ratio compare to TMO and DHR?
Oxford BioDynamics' 6-Month Share Buyback Ratio of -119.19 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Share Buyback Ratio for a Medical Diagnostics & Research company?
A good 6-Month Share Buyback Ratio depends on the Medical Diagnostics & Research industry context. However, 6-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Share Buyback Ratio mean?
A high 6-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 6-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past six months, calculated as the percentage change in shares outstanding from two quarters ago to the current quarter. View historical data for Oxford BioDynamics and its competitors. Oxford BioDynamics's current 6-Month Share Buyback Ratio is -119.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford BioDynamics stock overvalued right now?
Based on GuruFocus' analysis, Oxford BioDynamics (OXBOF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 85% below its estimated fair value. The current 6-Month Share Buyback Ratio is -119.19. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Share Buyback Ratio calculated?
6-Month Share Buyback Ratio is calculated from a company's financial statements. For Oxford BioDynamics (OXBOF), the current 6-Month Share Buyback Ratio is -119.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oxford BioDynamics Business Description

Other Exchanges OBD:UKLMQ:Germany
Address John Smith Drive, 3140 Rowan Place, Oxford Business Park South, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company focused on advancing personalized healthcare through the development and commercialization of precision medicine tests for serious and impactful diseases. The company is engaged in the commercialisation of proprietary molecular diagnostics products and biomarker research and development. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The company generates revenue from the sales of proprietary products and biomarker research and development. Geographically, it generates the maximum revenue from the USA.